Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Gains from Sales and Divestitures: 2018

Historic Gains from Sales and Divestitures for Rockwell Medical (RMTI) over the last 1 years, with Dec 2018 value amounting to $98,500.

  • Rockwell Medical's Gains from Sales and Divestitures was N/A to $96,542 in Q3 2019 from the same period last year, while for Sep 2019 it was $96,542, marking a year-over-year change of. This contributed to the annual value of $98,500 for FY2018, which is N/A change from last year.
  • Latest data reveals that Rockwell Medical reported Gains from Sales and Divestitures of $98,500 as of FY2018.
  • Over the past 5 years, Rockwell Medical's Gains from Sales and Divestitures peaked at $98,500 during FY2018, and registered a low of $98,500 during FY2018.
  • Moreover, its 1-year median value for Gains from Sales and Divestitures was $98,500 (2018), whereas its average is $98,500.